Savalia NK
Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA; Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT 06511, USA; Medical Scientist Training Program, Yale University School of Medicine, New Haven, CT 06511, USA.
PreprintPsilocybin
Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors
PreprintPsilocybin
Psilocybin reshapes cortical inhibition through selective interneuron recruitment
ArticlePsilocybin
Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks.
PreprintPsilocybin
Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks
ArticlePsilocybin
Psilocybin's lasting action requires pyramidal cell types and 5-HT<sub>2A</sub> receptors.
PreprintPsilocybin
Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expression
PreprintPsilocybin
Pyramidal cell types and 5-HT <sub>2A</sub> receptors are essential for psilocybin’s lasting drug action
ArticlePsilocybin
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.
ArticleKetamine